20 recruiting. 20 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 20 | Recruiting 20 |
Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Formulations mRNA-1273, mRNA-1283 - SARS-CoV-2 | Phase 4 | Recruiting | ModernaTX, Inc. | 300 | 2026-10-09 | 2026-10-27 |
| Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and People at Increased Risk of Severe COVID-19 Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M - COVID-19 | Phase 4 | Recruiting | Sanofi | 660 | 2026-10-01 | 2026-10-15 |
| A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age BNT162b2 Vaccine, Tdap Vaccine - COVID-19 Vaccines | Phase 4 | Recruiting | BioNTech SE | 200 | 2026-07-23 | 2026-08-07 |
| Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Therapy in Critically Ill Patients With Ventilator-associated Pneumonia strategy combining respiratory mPCR and algorithm-based therapy developed using local epidemiology - Ventilator Associated Pneumonia ( VAP) | Phase 4 | Recruiting | Centre Hospitalier Universitaire de Nīmes | 124 | 2026-03-27 | 2026-10-13 |
| Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP) Methylprednisolone (drug), hydrocortisone - Community Acquired Pneumonia (CAP) | Phase 4 | Recruiting | Copenhagen Respiratory Research | 1600 | 2026-03-10 | 2026-03-18 |
| Opportunistic Pneumococcal Immunisation Trial in MALnutrition Pneumococcal conjugate vaccine, Typhoid conjugate vaccine - Severe Acute Malnutrition in Childhood, Pneumococcal Disease | Phase 4 | Recruiting | Nick Fancourt | 214 | 2026-01-16 | 2026-10-08 |
| Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia wether apply enhanced oral care combined with prophylactic antibiotics - Hemorrhage, Pneumonia | Phase 4 | Recruiting | Beijing Tiantan Hospital | 440 | 2026-01-07 | 2026-02-12 |
| Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study Pfizer-BioNTech mRNA COVID-19 vaccine, Novavax recombinant protein vaccine - COVID -19, COVID - 19 | Phase 4 | Recruiting | Henry M. Jackson Foundation for the Advancement of Military Medicine | 54 | 2025-11-12 | 2026-10-28 |
| Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams Doxycycline, Azithromycin - Community-acquired Pneumonia | Phase 4 | Recruiting | Mayo Clinic | 1120 | 2025-09-15 | 2026-09-24 |
| Effect of Vitamin C on Length of Hospital Stay in Children With Severe Pneumonia Antibiotics administration, Vitamin C - Pneumonia Childhood, Vitamin C | Phase 4 | Recruiting | Children's Hospital and Institute of Child Health, Multan | 90 | 2025-08-28 | 2026-02-17 |
| Gastrointestinal Dysmotility on Aspiration Risk Prucalopride, Famotidine - Esophageal Motility Disorders, Gastric Motor Dysfunction | Phase 4 | Recruiting | Boston Children's Hospital | 120 | 2025-02-13 | 2026-08-03 |
| A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis Inhaled amikacin, Placebo - Hepatic Encephalopathy, Cirrhosis | Phase 4 | Recruiting | Asian Institute of Gastroenterology, India | 162 | 2025-02-12 | 2025-04-04 |
| Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial Nirmatrelvir/ritonavir, Remdesivir - SARS CoV-2 Post-Acute Sequelae | Phase 4 | Recruiting | Mount Sinai Hospital, Canada | 118 | 2025-01-03 | 2025-01-24 |
| A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations mRNA-1273 Variant-containing Formulation - SARS-CoV-2 | Phase 4 | Recruiting | ModernaTX, Inc. | 1144 | 2024-09-09 | 2026-03-27 |
| Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP Ampicillin for Injection, Ceftriaxone for Injection, Amoxicillin - Community Acquired Pneumonia in Children | Phase 4 | Recruiting | Medical College of Wisconsin | 236 | 2024-08-22 | 2026-03-02 |
| Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Autoimmune Inflammatory Rheumatic Disease | Phase 4 | Recruiting | Tongji Hospital | 800 | 2024-07-20 | 2024-10-01 |
| Anti-viral Action Against Type 1 Diabetes Autoimmunity Comirnaty Injectable Product, Sodium Chloride 0.9% Inj - Diabetes Mellitus, Type 1 | Phase 4 | Recruiting | Technical University of Munich | 2252 | 2024-05-08 | 2025-09-23 |
| Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program. Ritonavir-Boosted Nirmatrelvir (Paxlovid), Physiological Evaluation, Moderna COVID-19 Vaccine - COVID-19, Long Haul | Phase 4 | Recruiting | Well- Konnect Healthcare Services and Research Firm | 100 | 2024-03-01 | 2024-11-27 |
| EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics Rapid Diagnostics - Blood Stream Infections, Ventilator Associated Pneumonia | Phase 4 | Recruiting | National University of Singapore | 1526 | 2023-12-12 | 2026-10-22 |
| A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo - COVID-19 | Phase 4 | Recruiting | University of Chicago | 280 | 2023-07-01 | 2025-11-10 |
COVID-19 (7) · Community-Acquired Pneumonia (3) · Coronavirus Infections (3) · Pneumonia, Ventilator-Associated (3) · Virus Diseases (3) · Post-Acute COVID-19 Syndrome (2) · Autoimmune Diseases (1) · Cerebral Hemorrhage (1) · Connective Tissue Diseases (1) · Coronaviridae Infections (1) · Cross Infection (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Esophageal Motility Disorders (1)
Infections (19) · Respiratory Tract Diseases (19) · Respiratory Tract Infections (19) · Lung Diseases (16) · Coronaviridae Infections (8) · Nidovirales Infections (8) · Pneumonia, Viral (8) · RNA Virus Infections (8) · Coronavirus Infections (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Virus Diseases (6) · Disease Attributes (5) · Community-Acquired Infections (3)
2019-nCoV Vaccine mRNA-1273 (2) · BNT162 Vaccine (2) · Injections (2) · nirmatrelvir and ritonavir drug combination (2) · Amoxicillin (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Ampicillin (1) · Ascorbic Acid (1) · Azithromycin (1) · Cefprozil (1) · Ceftriaxone (1) · Clindamycin (1) · DNA, Recombinant (1) · Doxycycline (1) · Famotidine (1)
ModernaTX, Inc. (2) · Asian Institute of Gastroenterology, India (1) · Beijing Tiantan Hospital (1) · BioNTech SE (1) · Boston Children's Hospital (1) · Centre Hospitalier Universitaire de Nīmes (1) · Children's Hospital and Institute of Child Health, Multan (1) · Copenhagen Respiratory Research (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Mayo Clinic (1) · Medical College of Wisconsin (1) · Mount Sinai Hospital, Canada (1) · National University of Singapore (1) · Nick Fancourt (1) · Sanofi (1)
United States (10) · China (2) · India (2) · Austria (1) · Belgium (1) · Canada (1) · Denmark (1) · France (1) · Germany (1) · Malaysia (1) · Pakistan (1) · Singapore (1) · South Korea (1) · Sweden (1) · Taiwan (1)
Anette-G. Ziegler (1) · Ayesha F Assitant Professor, FCPS (1) · Brandon Baird (1) · David Paterson, Professor (1) · Edward Mitre, MD (1) · Junping Guo (1) · Kawana J Williams, Ph.D. (1) · Lingli Dong (1) · Michelle Mitchell (1) · Ognjen Gajic, MD MS (1) · Yewande Odeyemi, MBBS MS (1)
R61HL183016 (1)